Marco Mielcarek

发表

Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.

M. Mielcarek, P. Martin, B. Torok-Storb, 1997, Blood.

Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients.

D. Mager, Wei Gao, J. McCune, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

R. Storb, T. Gooley, T. Furlong, 2023, Transplantation and cellular therapy.

Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD.

T. Schmidt, Michael C. Wu, D. Fredricks, 2019, Blood advances.

HHV-6 Reactivation and Disease after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis.

Meei-Li W Huang, K. Jerome, E. Krantz, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation.

M. Mielcarek, B. Torok-Storb, L. Graf, 1998, Blood.

Late effects of severe acute GVHD on quality of life, medical comorbidities and survival.

Stephanie J. Lee, E. Krakow, L. Onstad, 2022, Transplantation and cellular therapy.

Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

B. Sandmaier, D. Fredricks, S. Pergam, 2023, JAMA network open.

CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma.

M. Mielcarek, B. Torok-Storb, B. Roecklein, 1996, Blood.

Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization.

L. Holmberg, A. Portuguese, D. Green, 2024, Transplantation and Cellular Therapy.

NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.

J. Bolaños-Meade, Y. Nieto, A. El-Jawahri, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Effective treatment of low risk acute GVHD with itacitinib monotherapy.

Z. DeFilipp, A. Alousi, M. Qayed, 2022, Blood.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Hematopoietic Cell Transplantation, Version 2.2020

Y. Nieto, V. Bhatt, A. El-Jawahri, 2020 .

Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.

Pavitra Roychoudhury, L. H. Yoke, M. Boeckh, 2024, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.